AstraZeneca (AZN) growth opportunities 'overlooked' - Jefferies

Go back to AstraZeneca (AZN) growth opportunities 'overlooked' - Jefferies

Amazon, Warner Bros, and Dow rise premarket; Nio, Nike, HP fall

September 25, 2023 7:58 AM EDT

Investing.com -- U.S. futures edged lower Monday, with investors still reeling from last weeks hawkish Federal Reserve meeting, while a U.S. government shutdown draws nearer.

Here are some of the biggest premarket U.S. stock movers today:

Amazon (NASDAQ: AMZN) stock rose 0.5% after the tech giant announced plans to invest up to $4... More

Jefferies Upgrades AstraZeneca (AZN) to Buy

September 25, 2023 3:20 AM EDT

Jefferies analyst Peter Welford upgraded AstraZeneca (NASDAQ: AZN) from Neutral to Buy with a price target of $80.00 (from $66.50).


For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.


Shares of AstraZeneca closed at $67.83 yesterday.

... More

Deutsche Bank Reiterates Hold Rating on AstraZeneca (AZN:LN) (AZN)

September 25, 2023 2:59 AM EDT

Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating and GBP110.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).

... More

AstraZeneca (AZN) PT Lowered to $81.70 at Berenberg

September 25, 2023 2:44 AM EDT

Berenberg lowered its price target on AstraZeneca (NASDAQ: AZN) to $81.70 (from $83.90) while maintaining a Buy rating.... More

Berenberg Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)

September 25, 2023 2:42 AM EDT

Berenberg analyst Luisa Hector reiterated a Buy rating and GBP133.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).

... More

Jefferies Upgrades AstraZeneca (AZN:LN) (AZN) to Buy

September 24, 2023 9:22 PM EDT

Jefferies analyst Peter Welford upgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Hold to Buy with a price target of GBP130.00 (from GBP105.00).

... More

Morgan Stanley Reiterates Overweight Rating on AstraZeneca (AZN:LN) (AZN)

September 23, 2023 8:01 AM EDT

Morgan Stanley analyst Mark Purcell reiterated an Overweight rating and GBP127.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).

... More